Home » VICAL VACCINE GETS $2.6M FEDERAL GRANT
VICAL VACCINE GETS $2.6M FEDERAL GRANT
Biopharmaceutical firm Vical Inc. said Wednesday it qualifies for accelerated access to $2.6 million in funding to further develop an avian flu vaccine.
MSN Money
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May